25 min listen
NEJM Interview: Dr. Jerry Avorn on the FDA Amendments Act of 2007 and the effort to make data on drug safety more transparent and available.
FromNEJM Interviews
NEJM Interview: Dr. Jerry Avorn on the FDA Amendments Act of 2007 and the effort to make data on drug safety more transparent and available.
FromNEJM Interviews
ratings:
Length:
10 minutes
Released:
Sep 19, 2018
Format:
Podcast episode
Description
Dr. Jerry Avorn is a professor of medicine at Harvard Medical School and a member of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn, A. Kesselheim, and A. Sarpatwari. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later. N Engl J Med 2018;379:1097-9.
Released:
Sep 19, 2018
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Howard Brody on the ethics of rationing and waste avoidance in health care. by NEJM Interviews